Rosy Debuts New Content Focused on Menopause and Migraine Education

StreetInsider04-18

The Women's Health Platform Will Make Evidence-Based Resources More Accessible. DALLAS, April 18, 2024 /PRNewswire-PRWeb/ -- Rosy, the Webby Award winning app-based platform that addresses common ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2428591514?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-18 21:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2428591514","market":"us","top_or_hot":-1,"title":"Rosy Debuts New Content Focused on Menopause and Migraine Education","media":"StreetInsider","content":"<div>\n<p>The Women's Health Platform Will Make Evidence-Based Resources More Accessible.\nDALLAS, April 18, 2024 /PRNewswire-PRWeb/ -- Rosy, the Webby Award winning app-based platform that addresses common ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=23083699\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rosy Debuts New Content Focused on Menopause and Migraine Education</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRosy Debuts New Content Focused on Menopause and Migraine Education\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-18 21:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=23083699><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Women's Health Platform Will Make Evidence-Based Resources More Accessible.\nDALLAS, April 18, 2024 /PRNewswire-PRWeb/ -- Rosy, the Webby Award winning app-based platform that addresses common ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=23083699\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0289739699.SGD","symbol_name":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=23083699","article_id":"2428591514","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2428591514","pubTimestamp":1713447000,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"The Women's Health Platform Will Make Evidence-Based Resources More Accessible.DALLAS, April 18, 2024 /PRNewswire-PRWeb/ -- Rosy, the Webby Award winning app-based platform that addresses common health concerns for women throughout their lifespans, announces an expanded focus beyond sexual wellness. Through its new sponsorship from Pfizer, one of the world's premier biopharmaceutical companies, Rosy will provide women in the U.S. with free evidence-based resources, rolled out in two phases. The first will focus on menopause and the second on migraine, with the overall goal of empowering women to take their health into their own hands.During phase two, focus will shift towards patient awareness modules tailored to the unique needs of women suffering from migraine, including diagnosis, symptoms, and treatment options. Migraine is the leading cause of disability worldwide among young adult women, with reproductive hormones often playing a role in their frequency. While migraine symptoms a","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","BK4581":"高盛持仓","SG9999001176.USD":"United Global Healthcare Acc USD","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4588":"碎股","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","LU0058720904.USD":"联博国际健康护理基金A","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4592":"伊斯兰概念","BK4534":"瑞士信贷持仓","LU0234572021.USD":"高盛美国核心股票组合Acc","SG9999002232.USD":"Allianz Global High Payout USD","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999002224.SGD":"Allianz Global High Payout SGD","BK4007":"制药","BK4585":"ETF&股票定投概念","PFE":"辉瑞","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC"},"translate_title":"Rosy推出关注更年期和偏头痛教育的新内容","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.81},"content_text":"The Women's Health Platform Will Make Evidence-Based Resources More Accessible.\nDALLAS, April 18, 2024 /PRNewswire-PRWeb/ -- Rosy, the Webby Award winning app-based platform that addresses common health concerns for women throughout their lifespans, announces an expanded focus beyond sexual wellness. Through its new sponsorship from Pfizer, one of the world's premier biopharmaceutical companies, Rosy will provide women in the U.S. with free evidence-based resources, rolled out in two phases. The first will focus on menopause and the second on migraine, with the overall goal of empowering women to take their health into their own hands.\nWe're thrilled to be building out our network and offering free educational resources to women, empowering them to confidently take action regarding important, lifetime health concerns.Lyndsey Harper MD (Rosy's CEO and Founder) created the first-of-its-kind app to bring women personalized solutions for their health and wellness; the platform supports adult women across their lifecycle, from hormonal health through menopause and beyond. Rosy currently serves women between 17 - 91 years old. When signing up for Rosy, each user takes a comprehensive Wellness Quiz, allowing Rosy to personalize an evidence-based, CBT-informed program with their unique concerns and priorities in mind. Since launching in 2019, Dr. Harper and her team have firmly established Rosy's evidence-based approach – more than 11% of OB/GYNs nationwide recommend Rosy to their patients. While initially focused on sexual wellness, Rosy has expanded to include a wider range of women's health concerns, including endometriosis, PCOS, and more.\nEach year, an estimated 1 million Americans reach menopause, which can coincide with symptoms like vaginal dryness, decreased sensation and libido, pelvic floor issues, and urinary problems. Historically, these issues have gone ignored and unaddressed, with 73% of women not receiving treatment. Through the first phase of the sponsorship from Pfizer, Rosy will create a series of modules to increase awareness surrounding menopause-related topics; these include symptoms, diagnosis, lifestyle change to support symptom relief, and potential treatment options. By equipping patients with knowledge and resources specific to menopause and their unique health concerns and goals, the aim is to empower them to make informed decisions and enhance their overall wellbeing.\nDuring phase two, focus will shift towards patient awareness modules tailored to the unique needs of women suffering from migraine, including diagnosis, symptoms, and treatment options. Migraine is the leading cause of disability worldwide among young adult women, with reproductive hormones often playing a role in their frequency. While migraine symptoms are extremely common, with 1 in 5 women suffering from them worldwide, many people go undiagnosed and untreated for a variety of reasons. Rosy aims to better inform women about migraine symptoms so that they seek out a medical professional and discuss solutions that improve their quality of life.\n\"We're thrilled to be building out our network and offering free educational resources to women, empowering them to confidently take action regarding important, lifetime health concerns. Our larger goal is not just to inform women, but also provide them with personalized recommendations for evidence-based interventions to support them on their journey to optimal health. With continued scale, our educational modules have the ability to change not only the health of individuals, but the health of larger populations as well.\" said Lyndsey Harper, MD, Founder and CEO of Rosy.\nPhysicians, providers, and hospital systems interested in recommending Rosy to their female patients are welcome to email [email protected]. For media inquiries, please contact [email protected].\nAbout Rosy:\nRosy is a first-of-its-kind platform that offers personalized and holistic solutions for women's wellness. Originally focused on sexual health, the app has expanded into other underserved aspects of women's health, including endometriosis, fibroids, menopause, migraines, and more. Offerings include customized Wellness Plans, individual and group intimacy coaching, audio and written erotica, educational videos, supportive online community, and much more. Rosy is the first physician-founded platform supporting women throughout their lifetime.\nIn 2022, Rosy won the UCSF Digital Health Rising Star Award in the Consumer Wellness Category, as well as the Webby Award for Best Visual Design - Aesthetic in the Apps and Software Category and in 2023, Lyndsey Harper, MD and Rosy were awarded the Women's Health Innovation Summit (WHIS) Judge's Choice Award.\nWebsite: https://meetrosy.com/\nInstagram: @meet_rosy\nLinkedin: https://www.linkedin.com/company/meet_rosy/\nThe Rosy App: https://meetrosy.app.link/h1yxnl3eknb\nMedia Contact\nRachel Van Dolsen, Band of Insiders, 1 9142604636, [email protected], https://www.rachelvandolsen.com/\n View original content to download multimedia:https://www.prweb.com/releases/rosy-debuts-new-content-focused-on-menopause-and-migraine-education-302119387.html\nSOURCE Rosy","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2428591514"}